Global Rare Disease Genetic Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Next-Generation Sequencing (NGS)
1.2.3 Array Technology
1.2.4 PCR-based Testing
1.2.5 Fluorescence in Situ Hybridization (FISH)
1.2.6 Sanger Sequencing
1.2.7 Karyotyping
1.2.8 Others
1.3 Market by Application
1.3.1 Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026
1.3.2 Research Laboratories and CROs
1.3.3 Diagnostic Laboratories
1.3.4 Hospitals and Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Genetic Testing Market Perspective (2015-2026)
2.2 Global Rare Disease Genetic Testing Growth Trends by Regions
2.2.1 Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rare Disease Genetic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Genetic Testing Players by Market Size
3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2015-2020)
3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2015-2020)
3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2019
3.5 Key Players Rare Disease Genetic Testing Area Served
3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
3.7 Date of Enter into Rare Disease Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Genetic Testing Breakdown Data by Type (2015-2026)
4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2015-2020)
4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2021-2026)
5 Rare Disease Genetic Testing Breakdown Data by Application (2015-2026)
5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2015-2020)
5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rare Disease Genetic Testing Market Size (2015-2026)
6.2 North America Rare Disease Genetic Testing Market Size by Type (2015-2020)
6.3 North America Rare Disease Genetic Testing Market Size by Application (2015-2020)
6.4 North America Rare Disease Genetic Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Rare Disease Genetic Testing Market Size (2015-2026)
7.2 Europe Rare Disease Genetic Testing Market Size by Type (2015-2020)
7.3 Europe Rare Disease Genetic Testing Market Size by Application (2015-2020)
7.4 Europe Rare Disease Genetic Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Rare Disease Genetic Testing Market Size (2015-2026)
8.2 China Rare Disease Genetic Testing Market Size by Type (2015-2020)
8.3 China Rare Disease Genetic Testing Market Size by Application (2015-2020)
8.4 China Rare Disease Genetic Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Rare Disease Genetic Testing Market Size (2015-2026)
9.2 Japan Rare Disease Genetic Testing Market Size by Type (2015-2020)
9.3 Japan Rare Disease Genetic Testing Market Size by Application (2015-2020)
9.4 Japan Rare Disease Genetic Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Rare Disease Genetic Testing Market Size (2015-2026)
10.2 Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Rare Disease Genetic Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020))
11.1.5 Quest Diagnostics Recent Development
11.2 Centogene
11.2.1 Centogene Company Details
11.2.2 Centogene Business Overview
11.2.3 Centogene Rare Disease Genetic Testing Introduction
11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.2.5 Centogene Recent Development
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Details
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.3.5 Invitae Corporation Recent Development
11.4 3billion
11.4.1 3billion Company Details
11.4.2 3billion Business Overview
11.4.3 3billion Rare Disease Genetic Testing Introduction
11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.4.5 3billion Recent Development
11.5 Arup Laboratories
11.5.1 Arup Laboratories Company Details
11.5.2 Arup Laboratories Business Overview
11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.5.5 Arup Laboratories Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Details
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.6.5 Eurofins Scientific Recent Development
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.7.5 Strand Life Sciences Recent Development
11.8 Ambry Genetics
11.8.1 Ambry Genetics Company Details
11.8.2 Ambry Genetics Business Overview
11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.8.5 Ambry Genetics Recent Development
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Details
11.9.2 Perkin Elmer Business Overview
11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.9.5 Perkin Elmer Recent Development
11.10 Macrogen
11.10.1 Macrogen Company Details
11.10.2 Macrogen Business Overview
11.10.3 Macrogen Rare Disease Genetic Testing Introduction
11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020)
11.10.5 Macrogen Recent Development
11.11 Baylor Genetics
10.11.1 Baylor Genetics Company Details
10.11.2 Baylor Genetics Business Overview
10.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
10.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.11.5 Baylor Genetics Recent Development
11.12 Color Genomics
10.12.1 Color Genomics Company Details
10.12.2 Color Genomics Business Overview
10.12.3 Color Genomics Rare Disease Genetic Testing Introduction
10.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.12.5 Color Genomics Recent Development
11.13 Preventiongenetics
10.13.1 Preventiongenetics Company Details
10.13.2 Preventiongenetics Business Overview
10.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
10.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.13.5 Preventiongenetics Recent Development
11.14 Progenity
10.14.1 Progenity Company Details
10.14.2 Progenity Business Overview
10.14.3 Progenity Rare Disease Genetic Testing Introduction
10.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.14.5 Progenity Recent Development
11.15 Coopersurgical
10.15.1 Coopersurgical Company Details
10.15.2 Coopersurgical Business Overview
10.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
10.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.15.5 Coopersurgical Recent Development
11.16 Fulgent Genetics
10.16.1 Fulgent Genetics Company Details
10.16.2 Fulgent Genetics Business Overview
10.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
10.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.16.5 Fulgent Genetics Recent Development
11.17 Myriad Genetics
10.17.1 Myriad Genetics Company Details
10.17.2 Myriad Genetics Business Overview
10.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
10.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.17.5 Myriad Genetics Recent Development
11.18 LabCorp
10.18.1 LabCorp Company Details
10.18.2 LabCorp Business Overview
10.18.3 LabCorp Rare Disease Genetic Testing Introduction
10.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.18.5 LabCorp Recent Development
11.19 Opko Health
10.19.1 Opko Health Company Details
10.19.2 Opko Health Business Overview
10.19.3 Opko Health Rare Disease Genetic Testing Introduction
10.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020)
10.19.5 Opko Health Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Next-Generation Sequencing (NGS)
Table 4. Key Players of Array Technology
Table 5. Key Players of PCR-based Testing
Table 6. Key Players of Fluorescence in Situ Hybridization (FISH)
Table 7. Key Players of Sanger Sequencing
Table 8. Key Players of Karyotyping
Table 9. Key Players of Others
Table 10. Global Rare Disease Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Rare Disease Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Rare Disease Genetic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Rare Disease Genetic Testing Market Share by Regions (2015-2020)
Table 14. Global Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Rare Disease Genetic Testing Market Share by Regions (2021-2026)
Table 16. Rare Disease Genetic Testing Market Market Trends
Table 17. Rare Disease Genetic Testing Market Drivers
Table 18. Rare Disease Genetic Testing Market Challenges
Table 19. Rare Disease Genetic Testing Market Restraints
Table 20. Global Rare Disease Genetic Testing Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Rare Disease Genetic Testing Market Share by Players (2015-2020)
Table 22. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2019)
Table 23. Global Rare Disease Genetic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Rare Disease Genetic Testing Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Rare Disease Genetic Testing Market Size Share by Type (2015-2020)
Table 29. Global Rare Disease Genetic Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Rare Disease Genetic Testing Market Size Share by Application (2015-2020)
Table 31. Global Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Rare Disease Genetic Testing Market Size Share by Application (2021-2026)
Table 33. North America Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Rare Disease Genetic Testing Market Share by Type (2015-2020)
Table 35. North America Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Rare Disease Genetic Testing Market Share by Application (2015-2020)
Table 37. North America Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Rare Disease Genetic Testing Market Share by Country (2015-2020)
Table 39. Europe Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Rare Disease Genetic Testing Market Share by Type (2015-2020)
Table 41. Europe Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Rare Disease Genetic Testing Market Share by Application (2015-2020)
Table 43. Europe Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Rare Disease Genetic Testing Market Share by Country (2015-2020)
Table 45. China Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 46. China Rare Disease Genetic Testing Market Share by Type (2015-2020)
Table 47. China Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 48. China Rare Disease Genetic Testing Market Share by Application (2015-2020)
Table 49. China Rare Disease Genetic Testing Market Size by Region (US$ Million) (2015-2020)
Table 50. China Rare Disease Genetic Testing Market Share by Region (2015-2020)
Table 51. Japan Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Rare Disease Genetic Testing Market Share by Type (2015-2020)
Table 53. Japan Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Rare Disease Genetic Testing Market Share by Application (2015-2020)
Table 55. Japan Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Rare Disease Genetic Testing Market Share by Country (2015-2020)
Table 57. Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Rare Disease Genetic Testing Market Share by Type (2015-2020)
Table 59. Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Rare Disease Genetic Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Rare Disease Genetic Testing Market Share by Country (2015-2020)
Table 63. Quest Diagnostics Company Details
Table 64. Quest Diagnostics Business Overview
Table 65. Quest Diagnostics Product
Table 66. Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 67. Quest Diagnostics Recent Development
Table 68. Centogene Company Details
Table 69. Centogene Business Overview
Table 70. Centogene Product
Table 71. Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 72. Centogene Recent Development
Table 73. Invitae Corporation Company Details
Table 74. Invitae Corporation Business Overview
Table 75. Invitae Corporation Product
Table 76. Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 77. Invitae Corporation Recent Development
Table 78. 3billion Company Details
Table 79. 3billion Business Overview
Table 80. 3billion Product
Table 81. 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 82. 3billion Recent Development
Table 83. Arup Laboratories Company Details
Table 84. Arup Laboratories Business Overview
Table 85. Arup Laboratories Product
Table 86. Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 87. Arup Laboratories Recent Development
Table 88. Eurofins Scientific Company Details
Table 89. Eurofins Scientific Business Overview
Table 90. Eurofins Scientific Product
Table 91. Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 92. Eurofins Scientific Recent Development
Table 93. Strand Life Sciences Company Details
Table 94. Strand Life Sciences Business Overview
Table 95. Strand Life Sciences Product
Table 96. Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 97. Strand Life Sciences Recent Development
Table 98. Ambry Genetics Business Overview
Table 99. Ambry Genetics Product
Table 100. Ambry Genetics Company Details
Table 101. Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 102. Ambry Genetics Recent Development
Table 103. Perkin Elmer Company Details
Table 104. Perkin Elmer Business Overview
Table 105. Perkin Elmer Product
Table 106. Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 107. Perkin Elmer Recent Development
Table 108. Macrogen Company Details
Table 109. Macrogen Business Overview
Table 110. Macrogen Product
Table 111. Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 112. Macrogen Recent Development
Table 113. Baylor Genetics Company Details
Table 114. Baylor Genetics Business Overview
Table 115. Baylor Genetics Product
Table 116. Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 117. Baylor Genetics Recent Development
Table 118. Color Genomics Company Details
Table 119. Color Genomics Business Overview
Table 120. Color Genomics Product
Table 121. Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 122. Color Genomics Recent Development
Table 123. Preventiongenetics Company Details
Table 124. Preventiongenetics Business Overview
Table 125. Preventiongenetics Product
Table 126. Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 127. Preventiongenetics Recent Development
Table 128. Progenity Company Details
Table 129. Progenity Business Overview
Table 130. Progenity Product
Table 131. Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 132. Progenity Recent Development
Table 133. Coopersurgical Company Details
Table 134. Coopersurgical Business Overview
Table 135. Coopersurgical Product
Table 136. Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 137. Coopersurgical Recent Development
Table 138. Fulgent Genetics Company Details
Table 139. Fulgent Genetics Business Overview
Table 140. Fulgent Genetics Product
Table 141. Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 142. Fulgent Genetics Recent Development
Table 143. Myriad Genetics Company Details
Table 144. Myriad Genetics Business Overview
Table 145. Myriad Genetics Product
Table 146. Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 147. Myriad Genetics Recent Development
Table 148. LabCorp Company Details
Table 149. LabCorp Business Overview
Table 150. LabCorp Product
Table 151. LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 152. LabCorp Recent Development
Table 153. Opko Health Company Details
Table 154. Opko Health Business Overview
Table 155. Opko Health Product
Table 156. Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million)
Table 157. Opko Health Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Rare Disease Genetic Testing Market Share by Type: 2020 VS 2026
Figure 2. Next-Generation Sequencing (NGS) Features
Figure 3. Array Technology Features
Figure 4. PCR-based Testing Features
Figure 5. Fluorescence in Situ Hybridization (FISH) Features
Figure 6. Sanger Sequencing Features
Figure 7. Karyotyping Features
Figure 8. Others Features
Figure 9. Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026
Figure 10. Research Laboratories and CROs Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Rare Disease Genetic Testing Report Years Considered
Figure 15. Global Rare Disease Genetic Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 16. Global Rare Disease Genetic Testing Market Share by Regions: 2020 VS 2026
Figure 17. Global Rare Disease Genetic Testing Market Share by Regions (2021-2026)
Figure 18. Global Rare Disease Genetic Testing Market Share by Players in 2019
Figure 19. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Rare Disease Genetic Testing Revenue in 2019
Figure 21. North America Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. United States Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Canada Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Europe Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Germany Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. France Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. U.K. Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Italy Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Russia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Nordic Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Rest of Europe Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Asia-Pacific Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. China Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Japan Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. South Korea Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Southeast Asia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. India Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Australia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Asia-Pacific Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Latin America Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Middle East & Africa Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Rest of Middle East & Africa Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Quest Diagnostics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 49. Centogene Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 50. Invitae Corporation Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 51. 3billion Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 52. Arup Laboratories Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 53. Eurofins Scientific Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 54. Strand Life Sciences Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 55. Ambry Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 56. Perkin Elmer Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 57. Macrogen Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 58. Baylor Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 59. Color Genomics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 60. Preventiongenetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 61. Progenity Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 62. Coopersurgical Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 63. Fulgent Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 64. Myriad Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 65. LabCorp Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 66. Opko Health Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed